We have recently updated our Privacy Policy to include information regarding the cookies we collect. By continuing to use this website you agree to our Privacy Policy and Terms of Use. ACCEPT PATIENTS & CARE PARTNERS HEALTHCARE PROVIDERS OUR MEDICINES THERAPEUTIC FOCUS PROGRAMS & RESEARCH ABOUT US WORKING AT SAGE Sage Thoughts Investors/Media Clinical Trials Contact Us INSIGHTS & POINT OF VIEW Sage Thoughts Next MORE FROM Sage Thoughts VIEW MORE POSTPARTUM DEPRESSION: “IN THEIR WORDS” LEARN MORE THE FACTS ABOUT POSTPARTUM DEPRESSION LEARN MORE POSTPARTUM DEPRESSION: PLAN AHEAD, LEARN MORE, FIND SUPPORT LEARN MORE NEWS The latest from Sage PRESS RELEASES Sage Therapeutics Announces Third Quarter 2021 Financial Results and Highlights Pipeline and Business Progress EVENTS Sage Therapeutics Q3 2021 Financial Results Conference Call SAGE THOUGHTS At Sage, we believe we see possibilities where others do not and are working to find potential ways to treat people with brain health disorders. Sage Thoughts provides insights and points of view about brain health. SEE ALL NEWS PATIENTS & CARE PARTNERS Putting patients and their families first We are rethinking care and how it is delivered to help patients and families impacted by brain health disorders. POSTPARTUM DEPRESSION MAJOR DEPRESSIVE DISORDER PATIENT ADVOCACY PROGRAMS SEE OUR RESOURCES FOR PATIENTS HEALTHCARE PROVIDERS It’s an exciting time in neuroscience At Sage, our goal is to originate meaningfully differentiated drug candidates. We aim to discover new pathways to brain health by making medicines that matter so patients can get better, sooner. LEARN MORE ABOUT OUR APPROACH CLINICAL TRIALS A distinct approach to neuroscience drug development Sage is committed to developing new medicines to treat life-altering brain health disorders. LEARN MORE ABOUT OUR ONGOING CLINICAL TRIALS PIPELINE Advancing a Leading Brain Health Portfolio We seek to make a positive impact on the unmet treatment needs of patients by advancing product candidates from a robust development pipeline of potential brain health disorder treatments. LEARN MORE ABOUT OUR PROGRAMS AND RESEARCH CAREERS Rethinking brain health disorders to make life better for patients and their families Sage is a place where unconventional thinking to solve problems with new ideas is welcome - and where unconventional thinkers can imagine what's possible and do big. EXPERIENCE OUR CULTURE Patients & Care Partners Patient Advocacy Patient Advocacy Sponsorships & Grants Patient Support Find Community PPD Support Resources Healthcare Providers Visit the Sage Medical Hub Our Medicines Therapeutic Focus A New Approach to Brain Health Disorders GABA & NMDA Receptors Programs & Research Depressive Disorders Neurologic Disorders Neuropsychiatric Franchise COVID-19 ARDS Pipeline Clinical Trials Collaborations About Us Mission & Values Corporate Governance Our Team Partnering Corporate Social Responsibility Working at Sage Sage Thoughts Investors/Media Clinical Trials Contact Us Facebook Twitter Instagram LinkedIn © 2021 Sage Therapeutics, Inc Privacy Policy Terms of Use Community Guidelines Accessibility Site Map ZULRESSO, the ZULRESSO logo, and SAGE CENTRAL are registered trademarks of Sage Therapeutics, Inc. SAGE THERAPEUTICS and the SAGE THERAPEUTICS logo are trademarks of Sage Therapeutics, Inc. All other trademarks referenced herein are the property of their respective owners.